Literature DB >> 15171671

Multivitamin supplements for pregnant women. New insights.

Eric Ahn1, Alejandro A Nava-Ocampo, Gideon Koren.   

Abstract

QUESTION: One of my patients is planning pregnancy and has started taking multivitamin supplements. She is experiencing gastric discomfort. What are the alternatives? ANSWER: Gastric discomfort is usually related to iron intake; pregnant women could use supplements with less iron. Pregnant women need 0.4 to 1.0 mg of folic acid daily. If they have a family history of neural tube defects (NTDs), insulin-dependent diabetes mellitus, or epilepsy, or are currently taking valproic acid, carbamazepine, or antifolates (eg, sulfonamides), they are at intermediate-to-high risk of having babies with NTDs and need 4.0 to 5.0 mg of folic acid daily.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15171671      PMCID： PMC2214608     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  11 in total

1.  Effect of calcium carbonate on the absorption of levothyroxine.

Authors:  N Singh; P N Singh; J M Hershman
Journal:  JAMA       Date:  2000-06-07       Impact factor: 56.272

Review 2.  Quantifying the effect of folic acid.

Authors:  N J Wald; M R Law; J K Morris; D S Wald
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

Review 3.  Iron supplements: a common cause of drug interactions.

Authors:  N R Campbell; B B Hasinoff
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

4.  Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy.

Authors:  Gideon Koren; Radinka Boskovic; Marjie Hard; Caroline Maltepe; Yvette Navioz; Adrienne Einarson
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

Review 5.  Calcium supplementation and iron status of females.

Authors:  A Bendich
Journal:  Nutrition       Date:  2001-01       Impact factor: 4.008

6.  Folic acid food fortification is associated with a decline in neuroblastoma.

Authors:  Amy E French; Ron Grant; Sheila Weitzman; Joel G Ray; Marian J Vermeulen; Lillian Sung; Mark Greenberg; Gideon Koren
Journal:  Clin Pharmacol Ther       Date:  2003-09       Impact factor: 6.875

7.  Potential prevention of neural tube defects by assessment of women of childbearing age through monitoring of folate.

Authors:  Bhushan Kapur; Offie Porat Soldin; Gideon Koren
Journal:  Ther Drug Monit       Date:  2002-10       Impact factor: 3.681

8.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.

Authors:  A E Czeizel; I Dudás
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

9.  Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism.

Authors:  N R Campbell; B B Hasinoff; H Stalts; B Rao; N C Wong
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

10.  Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy?

Authors:  Inder J Chopra; Khansa Baber
Journal:  Metabolism       Date:  2003-01       Impact factor: 8.694
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.